Polyphor AG (SWX:POLN) will look for acquisitions. Gokhan Batur, Chief Executive Officer said "Furthermore, the company plans to strategically focus on rare diseases and orphan indications, especially in oncology with its pipeline and future licensing and acquisitions that we envision and Jeff might talk a bit further on this".